Randomized, Controlled Trial of the FGF21 Analogue Pegozafermin in NASH
New England Journal of Medicine · 14.09.2023 · 389 (11) · 998-1008
DOI: 10.1056/nejmoa2304286 ↗Kurz gefasst
Klinische Studie (Phase II) in der Zeitschrift New England Journal of Medicine, erschienen am 14.09.2023. Verfasst von Rohit Loomba und 16 weiteren Autor:innen. Beteiligte Einrichtung: From the NAFLD Research Center, Division of Gastroenterology and Hepatology, Department of Medicine, University of California, San Diego, La Jolla (R…. Hauptthemen laut MEDLINE: Fibroblast Growth Factors, Fibrosis, Gastrointestinal Agents, Non-alcoholic Fatty Liver Disease. Die Arbeit wurde bisher 541-mal zitiert (Crossref) und nennt 32 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIDDK NIH HHS, 89bio.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- From the NAFLD Research Center, Division of Gastroenterology and Hepatology, Department of Medicine, University of California, San Diego, La Jolla (R.L.), Velocity Clinical Research, Los Angeles (J.P.F.), and 89bio, San…
ORCID-Profile: Rohit Loomba, Naim Alkhouri, Juan P Frias
Förderung
- NIDDK NIH HHS
- 89bio
Zitieren
APA
Loomba, R., Sanyal, A. J., Kowdley, K. V., Bhatt, D. L., Alkhouri, N., Frias, J. P., Bedossa, P., Harrison, S. A., Lazas, D., Barish, R., Gottwald, M. D., Feng, S., Agollah, G. D., Hartsfield, C. L., Mansbach, H., Margalit, M., & Abdelmalek, M. F. (2023). Randomized, Controlled Trial of the FGF21 Analogue Pegozafermin in NASH. New England Journal of Medicine, 389(11), 998-1008. https://doi.org/10.1056/nejmoa2304286
Vancouver
Loomba R, Sanyal AJ, Kowdley KV, Bhatt DL, Alkhouri N, Frias JP, et al. Randomized, Controlled Trial of the FGF21 Analogue Pegozafermin in NASH. New England Journal of Medicine. 2023;389(11):998-1008. doi:10.1056/nejmoa2304286
BibTeX
@article{Loomba2023,
author = {Loomba, Rohit and Sanyal, Arun J and Kowdley, Kris V and Bhatt, Deepak L and Alkhouri, Naim and Frias, Juan P and Bedossa, Pierre and Harrison, Stephen A and Lazas, Donald and Barish, Robert and Gottwald, Mildred D and Feng, Shibao and Agollah, Germaine D and Hartsfield, Cynthia L and Mansbach, Hank and Margalit, Maya and Abdelmalek, Manal F},
title = {Randomized, Controlled Trial of the FGF21 Analogue Pegozafermin in NASH},
journal = {New England Journal of Medicine},
year = {2023},
volume = {389},
number = {11},
pages = {998--1008},
doi = {10.1056/nejmoa2304286}
}
EUVIMED